Long-Term Follow-Up of Hearing Loss in Biotinidase Deficiency

@article{Welling2007LongTermFO,
  title={Long-Term Follow-Up of Hearing Loss in Biotinidase Deficiency},
  author={D. Bradley Welling},
  journal={Journal of Child Neurology},
  year={2007},
  volume={22},
  pages={1055 - 1055}
}
  • D. Welling
  • Published 1 August 2007
  • Medicine
  • Journal of Child Neurology
differs from Alzheimer dementia where acetylcholine– producing cells are reduced. It is interesting that Dr Niederhofer mentions memantine as well in Alzheimer disease. In recent publications, Chez has shown that in 30 autistic spectrum disorder patients, clinical improvement in language and behavior using a clinical global impression rating was observed in clinical treatment with memantine. This drug, however, works in presumed excessive glutaminergic excitability also observed in autistic… 
4 Citations

Figures and Topics from this paper

Deficiência de biotinidase : aspectos clínicos , diagnósticos e triagem neonatal
Biotinidase deficiency is a hereditary metabolic disease with varied phenotypic expression in which there is a defect in the metabolism of biotin. The symptoms of the classic form are often
Biotinidase deficiency: clinical and diagnosis aspects and neonatal screening
TLDR
Biotinidase deficiency meets the World Health Organization criteria for neonatal screening because carriers are asymptomatic during this period of life, the disease’s high morbidity rate, and effective treatment with low cost.
Cost-Effectiveness Analysis of a National Newborn Screening Program for Biotinidase Deficiency
TLDR
This study indicates that NBS for BD is likely to be a cost-effective use of resources, and undertook extensive sensitivity analyses around the main model assumptions, including a probabilistic sensitivity analysis.
Acrodermatitis Enteropathica-Like Eruption with Neurological Symptoms
Two boys presented with recurrent scaly erythematous eruption resembling seborrheic dermatitis following episodes of infection. Lab test for both revealed low biotinidase level, which confirmed the

References

SHOWING 1-7 OF 7 REFERENCES
Galantamine in the Treatment of Adult Autism: A Report of Three Clinical Cases
  • M. Hertzman
  • Medicine
    International journal of psychiatry in medicine
  • 2003
TLDR
Verbal fluency increased in all patients, according to their caregivers, and cholinergic stimulation of the CNS serotonergic subsystem with galantamine may enhance expressive language and communication in autistic adults.
A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder.
  • A. Hardan, B. Handen
  • Psychology, Medicine
    Journal of child and adolescent psychopharmacology
  • 2002
TLDR
Double-blind, placebo-controlled investigations are needed to provide further evidence of the potential benefits of donepezil to patients with autistic disorder.
Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
TLDR
Improvements in both expressive speech and overall autistic behavior showed gains were statistically significant and supported the hypothesis that treatment with cholinergic enhancing drugs in autistic spectrum disorders yields positive therapeutic effects.
Complete Biotinidase Deficiency Presenting as Reversible Progressive Ataxia and Sensorineural Deafness
TLDR
Even without typical cutaneous findings or organic aciduria, biotinidase deficiency should be considered among the differential diagnosis in any child presenting with either episodic or progressive ataxia or sensorineural deafness as prompt diagnosis and treatment with biotin may induce an excellent recovery.
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain.
TLDR
These neurochemical abnormalities implicate the cholinergic system in developmental disorders such as autism and suggest the potential for intervention based on cholinerential receptor modulation.
Memantine experience in children and adolescents with autistic spectrum disorders
  • Ann Neurol
  • 2004
Donepezil use in children with autistic spectrum disorders
  • Ann Neurol
  • 2000